P
Paola Di Pietro
Researcher at University of Salerno
Publications - 47
Citations - 617
Paola Di Pietro is an academic researcher from University of Salerno. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 10, co-authored 22 publications receiving 281 citations.
Papers
More filters
Journal ArticleDOI
Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes
Valeria Conti,Graziamaria Corbi,Maria Vincenza Polito,Michele Ciccarelli,Valentina Manzo,Martina Torsiello,Emanuela De Bellis,Federica D'Auria,Gennaro Vitulano,Federico Piscione,Albino Carrizzo,Paola Di Pietro,Carmine Vecchione,Nicola Ferrara,Amelia Filippelli +14 more
TL;DR: Determining Sirt1 activity in PBMCs is useful to distinguish the HF patients’ phenotypes from each other, especially HFmrEF/HFrEF from HFpEF.
Journal ArticleDOI
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems
Valeria Visco,Carolina Vitale,Antonella Rispoli,Carmine Izzo,Nicola Virtuoso,G. Ferruzzi,Mario Santopietro,Americo Melfi,Mariangela Rusciano,Angelantonio Maglio,Paola Di Pietro,Albino Carrizzo,Gennaro Galasso,Alessandro Vatrella,Carmine Vecchione,Michele Ciccarelli +15 more
TL;DR: Long COVID is a complex syndrome with protracted heterogeneous symptoms, and patients who experience post-COVID-19 sequelae require personalized treatment as well as ongoing support.
Journal ArticleDOI
The Role of Oxidative Stress in Cardiovascular Aging and Cardiovascular Diseases.
Carmine Izzo,Paolo Vitillo,Paola Di Pietro,Valeria Visco,Andrea Strianese,Nicola Virtuoso,Michele Ciccarelli,Gennaro Galasso,Albino Carrizzo,Carmine Vecchione +9 more
TL;DR: In this article, the role of oxidative stress in age-related cardiovascular aging and diseases is highlighted, taking into account the molecular mechanisms, the structural and functional alterations, and the diseases accompanied to the cardiovascular aging process.
Journal ArticleDOI
Antidepressant activity of fingolimod in mice
Luigi di Nuzzo,Rosamaria Orlando,Cristina Tognoli,Paola Di Pietro,Giuseppe Bertini,Jessica Miele,Domenico Bucci,Marta Motolese,Sergio Scaccianoce,Alessandra Caruso,Gianluca Mauro,Carmine De Lucia,Giuseppe Battaglia,Valeria Bruno,Paolo F. Fabene,Ferdinando Nicoletti +15 more
TL;DR: Findings show for the first time that fingolimod exerts antidepressant‐like effect acting in a “disease‐dependent” manner, and raise the interesting possibility that the drug could relieve depressive symptoms in MS patients independently of its disease‐modifying effect on MS.
Journal ArticleDOI
Monomeric ß-amyloid interacts with type-1 insulin-like growth factor receptors to provide energy supply to neurons
Maria Laura Giuffrida,Marianna Flora Tomasello,Giuseppe Pandini,Filippo Caraci,Giuseppe Battaglia,Carla L. Busceti,Paola Di Pietro,Giuseppe Pappalardo,Francesco Attanasio,Santina Chiechio,Silvia Bagnoli,Benedetta Nacmias,Sandro Sorbi,Riccardo Vigneri,Enrico Rizzarelli,Ferdinando Nicoletti,Agata Copani +16 more
TL;DR: It is reported that the monomer of Aß1−42 activates type-1 insulin-like growth factor receptors and enhances glucose uptake in neurons and peripheral cells by promoting the translocation of the Glut3 glucose transporter from the cytosol to the plasma membrane.